$2500 | Single User
$5000 | Site License
$7500 | Enterprise License

Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H2, 2015
[Lowest Price Guaranteed: $2,500]

Published by Global Data: 30 Dec 2015 | 17929 | In Stock
Related Topics: Clinical Trials

Introduction

Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H2, 2015" provides an overview of Pelvic Inflammatory Disease (Pelvic Infections) clinical trials scenario. This report provides top line data relating to the clinical trials on Pelvic Inflammatory Disease (Pelvic Infections). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H2, 2015

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 4

    Report Guidance 5

    Clinical Trials by Region 6

    Clinical Trials and Average Enrollment by Country 7

    Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

    Top Five Countries Contributing to Clinical Trials in Europe 11

    Top Countries Contributing to Clinical Trials in North America 12

    Top Countries Contributing to Clinical Trials in Middle East and Africa 13

    Clinical Trials by G7 Countries: Proportion of Pelvic Inflammatory Disease (Pelvic Infections) to Infectious Disease Clinical Trials 14

    Clinical Trials by Phase in G7 Countries 16

    Clinical Trials in G7 Countries by Trial Status 17

    Clinical Trials by E7 Countries: Proportion of Pelvic Inflammatory Disease (Pelvic Infections) to Infectious Disease Clinical Trials 18

    Clinical Trials by Phase in E7 Countries 20

    Clinical Trials in E7 Countries by Trial Status 21

    Clinical Trials by Phase 22

    In Progress Trials by Phase 23

    Clinical Trials by Trial Status 24

    Clinical Trials by End Point Status 25

    Subjects Recruited Over a Period of Time 26

    Clinical Trials by Sponsor Type 27

    Prominent Sponsors 28

    Top Companies Participating in Pelvic Inflammatory Disease (Pelvic Infections) Therapeutics Clinical Trials 29

    Prominent Drugs 31

    Clinical Trial Profile Snapshots 32

    Appendix 49

    Abbreviations 49

    Definitions 49

    Research Methodology 50

    Secondary Research 50

    About GlobalData 51

    Contact Us 51

    Disclaimer 51

    Source 52

List Of Tables
in Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H2, 2015

List of Tables

Pelvic Inflammatory Disease (Pelvic Infections) Therapeutics, Global, Clinical Trials by Region, 2015* 6

Pelvic Inflammatory Disease (Pelvic Infections) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Pelvic Inflammatory Disease (Pelvic Infections) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Pelvic Inflammatory Disease (Pelvic Infections) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Pelvic Inflammatory Disease (Pelvic Infections) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Pelvic Inflammatory Disease (Pelvic Infections) Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Pelvic Inflammatory Disease (Pelvic Infections) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Proportion of Pelvic Inflammatory Disease (Pelvic Infections) to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 15

Pelvic Inflammatory Disease (Pelvic Infections) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Pelvic Inflammatory Disease (Pelvic Infections) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Pelvic Inflammatory Disease (Pelvic Infections) to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 19

Pelvic Inflammatory Disease (Pelvic Infections) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 20

Pelvic Inflammatory Disease (Pelvic Infections) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 21

Pelvic Inflammatory Disease (Pelvic Infections) Therapeutics, Global, Clinical Trials by Phase, 2015* 22

Pelvic Inflammatory Disease (Pelvic Infections) Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 23

Pelvic Inflammatory Disease (Pelvic Infections) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 24

Pelvic Inflammatory Disease (Pelvic Infections) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 25

Pelvic Inflammatory Disease (Pelvic Infections) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26

Pelvic Inflammatory Disease (Pelvic Infections) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27

Pelvic Inflammatory Disease (Pelvic Infections) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28

Pelvic Inflammatory Disease (Pelvic Infections) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30

Pelvic Inflammatory Disease (Pelvic Infections) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31

List Of Figures, Charts and Diagrams
in Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H2, 2015

List of Figures

Pelvic Inflammatory Disease (Pelvic Infections) Therapeutics, Global, Clinical Trials by Region (%), 2015* 6

Pelvic Inflammatory Disease (Pelvic Infections) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7

Pelvic Inflammatory Disease (Pelvic Infections) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Pelvic Inflammatory Disease (Pelvic Infections) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Pelvic Inflammatory Disease (Pelvic Infections) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Pelvic Inflammatory Disease (Pelvic Infections) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13

Proportion of Pelvic Inflammatory Disease (Pelvic Infections) to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 14

Pelvic Inflammatory Disease (Pelvic Infections) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Pelvic Inflammatory Disease (Pelvic Infections) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Pelvic Inflammatory Disease (Pelvic Infections) to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 18

Pelvic Inflammatory Disease (Pelvic Infections) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 20

Pelvic Inflammatory Disease (Pelvic Infections) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 21

Pelvic Inflammatory Disease (Pelvic Infections) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 22

Pelvic Inflammatory Disease (Pelvic Infections) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 23

Pelvic Inflammatory Disease (Pelvic Infections) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 24

Pelvic Inflammatory Disease (Pelvic Infections) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26

Pelvic Inflammatory Disease (Pelvic Infections) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27

Pelvic Inflammatory Disease (Pelvic Infections) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28

Pelvic Inflammatory Disease (Pelvic Infections) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29

Pelvic Inflammatory Disease (Pelvic Infections) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31

GlobalData Methodology 50

Additional Details

Publisher

Global Data

Publisher Information

Reference

17929 | GDHC3172CTIDB

Number of Pages

52

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Pelvic Muscle Probe-Global Market Status and Trend Report 2013-2023
Report SummaryPelvic Muscle Probe-Global Market Status and Trend Report 2013-2023 offers a comprehen...
23 Nov 2017 by MIReports USD $2,480 More Info
Pelvic Muscle Probe-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report SummaryPelvic Muscle Probe-Global Market Status & Trend Report 2013-2023 Top 20 Countries Dat...
23 Nov 2017 by MIReports USD $3,680 More Info
Pelvic Muscle Probe-North America Market Status and Trend Report 2013-2023
Report SummaryPelvic Muscle Probe-North America Market Status and Trend Report 2013-2023 offers a co...
23 Nov 2017 by MIReports USD $3,480 More Info
Pelvic Muscle Probe-South America Market Status and Trend Report 2013-2023
Report SummaryPelvic Muscle Probe-South America Market Status and Trend Report 2013-2023 offers a co...
23 Nov 2017 by MIReports USD $3,480 More Info
Pelvic Muscle Probe-Europe Market Status and Trend Report 2013-2023
Report SummaryPelvic Muscle Probe-Europe Market Status and Trend Report 2013-2023 offers a comprehen...
23 Nov 2017 by MIReports USD $3,480 More Info
Pelvic Muscle Probe-EMEA Market Status and Trend Report 2013-2023
Report SummaryPelvic Muscle Probe-EMEA Market Status and Trend Report 2013-2023 offers a comprehensi...
23 Nov 2017 by MIReports USD $3,480 More Info
Urinary Incontinence & Pelvic Organ Prolapse Devices Market Global Briefing 2017 Including: Sacral Neuromodulation, Vaginal Meshes, Urethral Inserts And Pessaries Covering: Coloplast, C. R. Bard Inc., Boston Scientific Corporation, Cook Medical, American Medical Systems
The global urinary incontinence & pelvic organ prolapse devices market was estimated to be around ...
27 Jul 2017 by The Business Research Company USD $1,000 More Info
Nephrology And Urology Devices Market Global Report 2017 Including: Dialysis Devices, Urinary Stone Devices, Incontinence & Pelvic Organ Prolapse Devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Endoscopy Devices Covering: Baxter International Inc., Fresenius Medical Care AG & Co KGaA, Cook Group Incorporated, B. Braun Group, and C. R. Bard Inc
Nephrology and urology devices are used in the treatment and diagnosis of diseases related to kidney...
17 Jul 2017 by The Business Research Company USD $6,000 More Info
Nephrology And Urology Devices Market Global Report 2017 Including: Dialysis Devices, Urinary Stone Devices, Incontinence & Pelvic Organ Prolapse Devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Endoscopy Devices Covering: Baxter International Inc., Fresenius Medical Care AG & Co KGaA, Cook Group Incorporated, B. Braun Group, and C. R. Bard Inc
Nephrology and urology devices are used in the treatment and diagnosis of diseases related to kidney...
17 Jul 2017 by The Business Research Company USD $6,000 More Info
Global Pelvic Organ Prolapse Repair Devices Market 2012- 2022
SummaryBased on products type, the report describes major products type share of regional market. Pr...
01 Mar 2017 by HeyReport USD $2,800 More Info

This report is published by Global Data

Download Free Report Summary PDF

Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H2, 2015 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...